Chemokine production by CBMC stimulated with poly(I:C)
Inflammatory mediator . | Production by CBMCs, pg/mL . | No. of experiments . | |
---|---|---|---|
Medium . | Poly(I:C) . | ||
CCL2 | 145 ± 81 | 2323 ± 1721* | 5 |
CCL4 | 34 | 465 ± 83† | 6 |
CCL5 | 93 ± 64 | 85 ± 48 | 5 |
CXCL2 | LD | 428 ± 154* | 6 |
CXCL8 | 202 ± 75 | 15712 ± 9229* | 6 |
CXCL9 | 8 ± 2 | 31 ± 25 | 5 |
CXCL10 | 133 ± 62 | 338 ± 174* | 6 |
CXCL11 | LD | LD | 5 |
GM-CSF | 312 ± 115 | 354 ± 138 | 5 |
IL-6 | 2135 ± 921 | 1088 ± 306 | 6 |
IFN-α | LD | LD | 4 |
LTC4 | LD | LD | 2 |
Inflammatory mediator . | Production by CBMCs, pg/mL . | No. of experiments . | |
---|---|---|---|
Medium . | Poly(I:C) . | ||
CCL2 | 145 ± 81 | 2323 ± 1721* | 5 |
CCL4 | 34 | 465 ± 83† | 6 |
CCL5 | 93 ± 64 | 85 ± 48 | 5 |
CXCL2 | LD | 428 ± 154* | 6 |
CXCL8 | 202 ± 75 | 15712 ± 9229* | 6 |
CXCL9 | 8 ± 2 | 31 ± 25 | 5 |
CXCL10 | 133 ± 62 | 338 ± 174* | 6 |
CXCL11 | LD | LD | 5 |
GM-CSF | 312 ± 115 | 354 ± 138 | 5 |
IL-6 | 2135 ± 921 | 1088 ± 306 | 6 |
IFN-α | LD | LD | 4 |
LTC4 | LD | LD | 2 |